Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Elevated expression of the enzyme ST6Gal 1 Sialyltransferase (ST6Gal-I) has been identified in the context of drug-resistant T-ALL / T-Cell Acute Lymphoblastic Leukemiacell lines, both in laboratory settings (in vitro) and within living organisms (in vivo). This heightened presence of ST6GAL1 is directly associated with the development of drug resistance in these cells.
Within T-ALL cell lines, a regulatory axis involving ZFAS1, miR-150, and ST6GAL1 has been observed. Specifically, miR-150, a type of microRNA, is found to be downregulated and exhibits an inverse relationship with the expression levels of ST6GAL1. ZFAS1, a long non-coding RNA, is identified as a direct target of miR-150. ZFAS1 positively influences the levels of ST6GAL1 by bind…